UBM Pharmaceutical Show Expands to SE Asia

Event organiser UBM Live, a subsidiary of UBM, unveiled the new CPhI South East Asia to take place in Jakarta next year. The debut exhibition is the latest geo-clone of UBM’s pharmaceutical exhibitions CPhI, which also includes CPhI India, Japan, China, South America and Worldwide.

CPhI South East Asia will be hosted at the Jakarta International Expo and run from May 10-12. UBM reports that Indonesia’s pharmaceutical market grew 10 percent last year and was valued at approximately US$3.9 billion. Exhibitor categories at the inaugural show will range from APIs, natural extracts to fine chemicals.

Greg Kerwin, UBM Pharma’s portfolio director, said, “Indonesia is the ideal location for the introduction of a new CPhI event. The Southeast Asia region is an exceptional example of a ‘pharmerging’ market and we feel that it is key to establish presence here at this time. ... The pharmaceutical market is growing across the region, and the increased demand for pharma raw materials offers great potential for international suppliers to expand their footprint in the ASEAN companies.”

Add new comment

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Image CAPTCHA
Enter the characters shown in the image.

Partner Voices

As event professionals and destinations adjust, adapt and evolve in these uncharted waters, it is imperative that substantial resources be put in place for all of the people responsible for planning and executing trade shows, expositions and conventions. An example is Mohegan Sun, which built an industry-leading, COVID-19 Resource Center with a combination of pictures from recently held successful events (the property reopened on May 1, 2020) along with several widely available and informative documents, such as an evolving operational framework: